multiBIND biotec
About:
multiBIND biotech develops products, patents, and technology for operations in molecular genetics and biomedicine.
Website: http://www.multibind.de
Top Investors: HTGF | High-Tech Gruenderfonds, Sirius Venture Partners
Description:
multiBIND is engaged in development of technologies, patents and products relating to operations in molecular genetics and biomedicine. Currently, the main focus of multiBIND is novel solutions in biological decontamination and disinfection, based on the bioDECONT® technology.
Total Funding Amount:
630000 EUR
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Köln, Nordrhein-Westfalen, Germany
Founded Date:
2005-01-01
Contact Email:
info(AT)multibind.de
Founders:
Number of Employees:
1-10
Last Funding Date:
2008-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai